[go: up one dir, main page]

TW362099B - Process for recovering a high-purity virus-inactivated factor VIII/von Willebrand factor complex by anion exchanger chromatography - Google Patents

Process for recovering a high-purity virus-inactivated factor VIII/von Willebrand factor complex by anion exchanger chromatography

Info

Publication number
TW362099B
TW362099B TW082100487A TW82100487A TW362099B TW 362099 B TW362099 B TW 362099B TW 082100487 A TW082100487 A TW 082100487A TW 82100487 A TW82100487 A TW 82100487A TW 362099 B TW362099 B TW 362099B
Authority
TW
Taiwan
Prior art keywords
anion exchanger
recovering
von willebrand
factor viii
exchanger chromatography
Prior art date
Application number
TW082100487A
Other languages
English (en)
Inventor
Monika Stadler
Horst Schwinn
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6451895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW362099(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of TW362099B publication Critical patent/TW362099B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW082100487A 1992-02-01 1993-01-28 Process for recovering a high-purity virus-inactivated factor VIII/von Willebrand factor complex by anion exchanger chromatography TW362099B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4204694A DE4204694C3 (de) 1992-02-01 1992-02-01 Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie

Publications (1)

Publication Number Publication Date
TW362099B true TW362099B (en) 1999-06-21

Family

ID=6451895

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082100487A TW362099B (en) 1992-02-01 1993-01-28 Process for recovering a high-purity virus-inactivated factor VIII/von Willebrand factor complex by anion exchanger chromatography

Country Status (16)

Country Link
US (1) US5714590A (zh)
EP (1) EP0625161B9 (zh)
JP (1) JP3556947B2 (zh)
KR (1) KR100240310B1 (zh)
AT (1) ATE203249T1 (zh)
AU (1) AU670776B2 (zh)
DE (2) DE4204694C3 (zh)
DK (1) DK0625161T4 (zh)
ES (1) ES2157920T5 (zh)
FI (1) FI109908B (zh)
GR (1) GR3036849T3 (zh)
NO (1) NO315426B1 (zh)
PT (1) PT625161E (zh)
RU (1) RU2096414C1 (zh)
TW (1) TW362099B (zh)
WO (1) WO1993015105A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2887329B2 (ja) * 1991-09-05 1999-04-26 バクスター インターナショナル インク 局所用フィブリノーゲン複合体
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
EP1148063A1 (de) 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
RU2253475C1 (ru) * 2004-02-02 2005-06-10 Общество с ограниченной ответственностью "Гемоцентр" Способ получения препарата фактора viii
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
RU2293570C2 (ru) * 2005-02-01 2007-02-20 Государственное учреждение Гематологический научный центр РАМН (ГУ ГНЦ РАМН) Способ обогащения фактором viii криопреципитата плазмы донорской крови
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
RU2579977C2 (ru) * 2009-11-13 2016-04-10 Грифольс Терапьютикс Инк. СОДЕРЖАЩИЕ ФАКТОР ФОН ВИЛЛЕБРАНДА (vWF) ПРЕПАРАТЫ И СПОСОБЫ, НАБОРЫ И ПРИМЕНЕНИЯ, СВЯЗАННЫЕ С НИМИ
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
DE3811042A1 (de) * 1988-03-31 1989-10-19 Merck Patent Gmbh Ionenaustauscher
ATE85220T1 (de) * 1988-05-27 1993-02-15 Centre Regional De Transfusion Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Also Published As

Publication number Publication date
JPH07503241A (ja) 1995-04-06
ES2157920T5 (es) 2007-12-16
PT625161E (pt) 2001-10-31
EP0625161B2 (en) 2007-05-16
ATE203249T1 (de) 2001-08-15
KR950700925A (ko) 1995-02-20
FI943545L (fi) 1994-07-28
JP3556947B2 (ja) 2004-08-25
ES2157920T3 (es) 2001-09-01
DK0625161T3 (da) 2001-09-24
EP0625161B1 (en) 2001-07-18
DE4204694A1 (de) 1993-08-12
AU670776B2 (en) 1996-08-01
NO942832D0 (no) 1994-07-29
GR3036849T3 (en) 2002-01-31
EP0625161A1 (en) 1994-11-23
DE69330458D1 (de) 2001-08-23
NO942832L (no) 1994-07-29
NO315426B1 (no) 2003-09-01
FI943545A0 (fi) 1994-07-28
FI109908B (fi) 2002-10-31
DK0625161T4 (da) 2007-09-03
EP0625161B9 (en) 2007-09-19
AU3351793A (en) 1993-09-01
RU2096414C1 (ru) 1997-11-20
DE69330458T3 (de) 2008-01-17
US5714590A (en) 1998-02-03
DE4204694C3 (de) 1995-10-12
DE4204694C2 (de) 1994-02-10
WO1993015105A1 (en) 1993-08-05
KR100240310B1 (ko) 2000-01-15
DE69330458T2 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
TW362099B (en) Process for recovering a high-purity virus-inactivated factor VIII/von Willebrand factor complex by anion exchanger chromatography
CA2098183A1 (en) Method for the purification of intact, correctly-folded insulin-like growth factor-1
HU905797D0 (en) Process for the preparation of the complex concentrate of blood-coagulating factor (viii) and von willebrand factor from complex plasma
DE359593T1 (de) Chromatographische trennung von plasmaproteinen.
EP0121976A3 (en) Partially purified osteogenic factor and process for preparing same from demineralized bone or an osteosarcoma
DE3650215D1 (de) Orientiertes, silanvernetztes Polyäthylen-Produkt von ultrahohem Molekulargewicht und Verfahren zu dessen Herstellung.
EP0492243A3 (en) Process for separating polymers from their solution, using fluids containing carbon dioxide
EP1308515A3 (en) Porcine factor VIII
UA27732C2 (uk) Спосіб приготування стандартизованого концентрату фактору віллебранда людини та концентрат, одержаний цим способом
GR3023203T3 (en) Treatment for asthma.
EP0383234A3 (de) Pasteurisiertes, gereinigtes von Willebrand-Faktor-Konzentrat und Verfahren zu seiner Herstellung
GB9205841D0 (en) Hydrocarbon resins,processes for their manufacture and adhesive compositions containing such resins
ATE34754T1 (de) Makromolekulare carbonylgruppen enthaltende produkte und verwendung zur extraktion von harnstoff.
AU693289B2 (en) Denatured low-density lipoprotein receptor
TW367335B (en) Cyclo-olefin polymers and preparation process thereof
RU94035758A (ru) Способ выделения высокоочищенного фактора yiii
HUP0301211A2 (hu) Vérzéscsillapító hatású vWF-tartalmú készítmény és eljárás annak előállítására
MY117328A (en) Production process for intravenous immune serum globulin and resultant product.
AU6487286A (en) Antihemophilic factor by cold precipitation
ES2006079A6 (es) Un procedimiento de preparacion de polimeros yodados.
CA2129045A1 (en) Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography
AU662084B2 (en) Process for reactivating purified membrane proteins
ATE229041T1 (de) Herstellung von schlagfestem polyethylen
ES8800353A1 (es) Procedimiento de clonacion de factor humano viii-r.
AU3876793A (en) Process for the inactivation of viruses in preparations of proteins

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees